Episode 867: One FDA Hint Skyrockets QURE Stock. SPRB： $500 When？ ｜ Uniqure, UnitedHealth Stock
The Shkreli Pill - Podcast készítő Urban Tapes
Kategóriák:
In this episode, Martin examines how a single FDA-related hint caused QURE stock to surge and what it reveals about market sensitivity to biotech news. He also discusses his outlook on SPRB, speculating on when it could reach the $500 mark, and provides analysis of Uniqure and UnitedHealth stocks within the broader healthcare landscape.
